Antibacterial and antivirulence activities of auranofin against Clostridium difficile
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference40 articles.
1. C. difficile infection: changing epidemiology and management paradigms;Vindigni;Clin Transl Gastroenterol,2015
2. Burden of Clostridium difficile infection in the United States;Lessa;N Engl J Med,2015
3. Epidemiology of Clostridium difficile infection;Depestel;J Pharm Pract,2013
4. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe;Warny;Lancet,2005
5. Both, toxin A and toxin B, are important in Clostridium difficile infection;Kuehne;Gut Microbes,2011
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile;mSphere;2024-07-30
2. The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug;Antibiotics;2024-07-15
3. Strategies for the design of analogs of auranofin endowed with anticancer potential;Expert Opinion on Drug Discovery;2024-05-27
4. Antibiotics: A “GOLDen” promise?;Coordination Chemistry Reviews;2024-02
5. New gold(III) complexes TGS 121, 404, and 702 show anti-tumor activity in colitis-induced colorectal cancer: an in vitro and in vivo study;Pharmacological Reports;2023-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3